Evidence map›Paper›PMID 38309760›Full record

ArticleBMJ open2024

Community health navigator-assisted transition of care from hospital to community: protocol for a randomised controlled trial.

Sharon M Parker, Parisa Aslani, Ben Harris-Roxas, Michael C Wright, Margo Barr, F Doolan-Noble, Sara Javanparast, Anurag Sharma, Richard H Osborne, John Cullen and 3 more

Abstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sharon M ParkerCentre for Primary Health Care and Equity, University of New South Wales, Sydney, New South Wales, Australia sharon.parker@unsw.edu.au sharon.parker@unsw.edu.au.ORCID 0000-0001-7904-6420
Parisa AslaniFaculty of Pharmacy, The University of Sydney, Sydney, New South Wales, Australia.
Ben Harris-RoxasSchool of Population Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0003-1716-2009
Michael C WrightHealth Economics Research and Evaluation, University of Technology, Sydney, New South Wales, Australia.
Margo BarrCentre for Primary Health Care and Equity, University of New South Wales, Sydney, New South Wales, Australia.
F Doolan-NobleGeneral Practice and Rural Health, University of Otago, Dunedin, New Zealand.
Sara JavanparastCollege of Nursing and Health Sciences, Flinders University, Adelaide, South Australia, Australia.ORCID 0000-0002-0388-5524
Anurag SharmaSchool of Population Health, University of New South Wales, Sydney, New South Wales, Australia.
Richard H OsborneFaculty of Health, Arts and Design, Swinburne University of Technology, Melbourne, Victoria, Australia.
John CullenAged Health, Rehabilitation and Chronic Care, Sydney Local Health District, Camperdown, New South Wales, Australia.
Elizabeth HarrisCentre for Primary Health Care and Equity, University of New South Wales, Sydney, New South Wales, Australia.
Fiona HaighCentre for Health Equity Training, Research and Evaluation, University of New South Wales, Sydney, New South Wales, Australia.
Mark HarrisCentre for Primary Health Care and Equity, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0002-0705-8913

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe objective of this parallel group, randomised controlled trial is to evaluate a community health navigator (CHN) intervention provided to patients aged over 40 years and living with chronic health conditions to transition from hospital inpatient care to their homes. Unplanned hospital readmissions are costly for the health system and negatively impact patients. METHODS AND ANALYSIS: Patients are randomised post hospital discharge to the CHN intervention or usual care. A comparison of outcomes between intervention and control groups will use multivariate regression techniques that adjust for age, sex and any independent variables that are significantly different between the two groups, using multiple imputation for missing values. Time-to-event analysis will examine the relationship between seeing a CHN following discharge from the index hospitalisation and reduced rehospitalisations in the subsequent 60 days and 6 months. Secondary outcomes include medication adherence, health literacy, quality of life, experience of healthcare and health service use (including the cost of care). We will also conduct a qualitative assessment of the implementation of the navigator role from the viewpoint of stakeholders including patients, health professionals and the navigators themselves. ETHICS APPROVAL: Ethics approval was obtained from the Research Ethics and Governance Office, Sydney Local Health District, on 21 January 2022 (Protocol no. X21-0438 and 2021/ETH12171). The findings of the trial will be disseminated through peer-reviewed journals and national and international conference presentations. Data will be deposited in an institutional data repository at the end of the trial. This is subject to Ethics Committee approval, and the metadata will be made available on request. TRIAL REGISTRATION NUMBER: Australian New Zealand Clinical Trials Registry (ACTRN 12622000659707). ARTICLE SUMMARY: The objective of this trial is to evaluate a CHN intervention provided to patients aged over 40 years and living with chronic health conditions to transition from hospital inpatient care to their homes.

Indexed as

Public HealthQuality of LifeAdultAustraliaHospitalsHumansMiddle AgedPatient TransferRandomized Controlled Trials as TopicChronic DiseasePatient NavigationPUBLIC HEALTH

Identifiers

PMID38309760
PMCPMC10840031

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.